NCT05900466View on ClinicalTrials.gov

Metformin for Fibromyalgia Symptoms (INFORM Trial)

PHASE2RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Fibromyalgia Syndrome
Interventions
DRUG

Metformin

500 mg Metformin ER tablets once daily in the morning for 8 weeks

DRUG

Placebo

Matching tablets once daily in the morning for 8 weeks

Trial Locations (1)

84132

RECRUITING

University of Utah, Salt Lake City

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

University of Utah

OTHER